Percutaneous Radiofrequency Ablation of Lung Neoplasms: Initial Therapeutic Response

Masao Akeboshi, Koichiro Yamakado, Atsuhiro Nakatsuka, +4

Journal of Vascular and Interventional Radiology

MedicinePercutaneous Radiofrequency AblationInterventional RadiologyPulmonary BlastomaOncology +2

Intratracheal Administration of Activated Protein C Inhibits Bleomycin-induced Lung Fibrosis in the Mouse

Hiroki Yasui, Esteban C. Gabazza, Shigenori Tamaki, +7

American Journal of Respiratory and Critical Care Medicine

Acute Lung InjuryInflammatory Lung DiseaseLung InflammationImmunologyPathology +15

Thrombin in the Airways of Asthmatic Patients

Esteban C. Gabazza, Osamu Taguchi, S Tamaki, +9

Lung

AsthmaAllergyHematologyImmunologyPulmonary Medicine +3

Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study

Koichi Takayama, Shinji Atagi, Fumio Imamura, +17

Supportive Care in Cancer

Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial

Kazuma Nagata, Takeo Horie, Naohiko Chohnabayashi, +37

American Journal of Respiratory and Critical Care Medicine

A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis

Corina N. D’Alessandro‐Gabazza, Tetsu Kobayashi, Taro Yasuma, +32

Nature Communications

Protein C Anticoagulant System in Patients with Interstitial Lung Disease

Hiroyasu Kobayashi, Esteban C. Gabazza, Osamu Taguchi, +8

American Journal of Respiratory and Critical Care Medicine

Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan

Ryo Morita, Kyoichi Okishio, Junichi Shimizu, +23

Lung Cancer

Activation of Protein C Pathway in the Airways

Osamu Hataji, Osamu Taguchi, Esteban C. Gabazza, +4

Lung

AsthmaTracheobronchitisSignal TransductionAllergyInflammatory Lung Disease +6

Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L)

Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, +19

Journal for ImmunoTherapy of Cancer